Vitamin D and follistatin as a 'growth machine': what the science says

What did @coach_kader1 actually say?

Honestly? Very little that's coherent. The transcript attributed to this video is largely incoherent filler, generic sign-off language, and what appears to be a badly garbled auto-transcription of Arabic or Algerian Darija speech. The actual verbal content we can evaluate is effectively zero. What we can work with is the caption, which is explicit: the creator claims that combining vitamin D with follistatin creates a "growth machine," framing it as a secret most people don't know. The hashtags confirm the core topic: follistatin, myostatin, and bodybuilding optimization. That's enough to fact-check, because those claims carry real-world consequences regardless of how the audio was transcribed.

The caption frames this as insider knowledge, reserved for an elite competition prep context. That framing is a red flag. Legitimate sports science doesn't hide behind exclusivity.

Does the science back this up?

Partially, and only in the loosest sense. Vitamin D has genuine, well-documented roles in muscle function. Follistatin is real, biologically significant, and legitimately studied. But the specific claim that combining them produces a synergistic anabolic "machine" is not supported by human clinical evidence as of 2024.

On vitamin D: a 2017 meta-analysis by Beaudart et al. in Osteoporosis International found modest positive effects of vitamin D supplementation on muscle strength in deficient populations, but the effects were not dramatic and disappeared in people with adequate levels. You're not unlocking a secret growth mechanism. You're correcting a deficiency.

On follistatin: it is a naturally occurring protein that inhibits myostatin, a negative regulator of muscle growth. The myostatin-follistatin axis is genuinely interesting science. Lee and McPherron's foundational work in Nature (1997) showed that myostatin knockout mice grew dramatically larger muscles. But that's mice. Human translation has been far less impressive. Clinical trials using myostatin inhibitors in humans, including studies by Becker et al. (2015) in JAMA Neurology, have shown limited functional benefits even in muscular dystrophy patients, let alone healthy athletes.

The idea that exogenous follistatin supplementation, whether through peptides or gene expression strategies, safely and meaningfully boosts muscle mass in healthy humans is not established science. It is speculative at best.

What did they get wrong (or right)?

Credit where it's due: the biological relationship between follistatin and myostatin is real and documented. The creator didn't invent this pathway. Vitamin D's role in muscle physiology is also legitimate, and raising awareness of widespread deficiency is genuinely useful public health content.

But the framing is where this goes wrong. Calling this combination a "growth machine" implies a potency and certainty that the evidence doesn't support. There is no human RCT showing that vitamin D plus follistatin supplementation produces meaningful hypertrophy above normal training responses. Not one.

If the creator is alluding to exogenous follistatin peptides, that's a different and more serious problem. Follistatin-344 and follistatin-315 are being sold in gray-market peptide markets, but they are not approved for human use, have no established human safety profile, and their systemic effects on myostatin inhibition could theoretically affect cardiac muscle as well as skeletal muscle. That risk is not small and is not discussed here.

Framing unproven, potentially risky compounds as secrets the fitness industry doesn't want you to know is a manipulation tactic, not education.

What should you actually know?

If you're vitamin D deficient, correcting that deficiency will likely improve muscle function, recovery, and overall health. That's worth doing. A serum 25(OH)D level below 30 ng/mL is common, especially in North Africa and the Middle East during winter months, and supplementation in that context is evidence-based and low-risk.

Follistatin as a supplemental strategy is a different category entirely. There is no oral supplement that meaningfully raises systemic follistatin to levels that inhibit myostatin in muscle tissue. Peptide-based or gene-therapy-based approaches exist in research settings but are not safe or legal for recreational use.

The myostatin-follistatin axis is one of the most watched areas in muscle biology research. But watching an axis in a lab and recommending people manipulate it at home are very different things. The science is early. The hype is not.

If you're training seriously and want to optimize recovery and muscle growth, the evidence-based list is short: progressive overload, adequate protein (1.6-2.2g/kg/day per Morton et al., 2018, BJSM), sleep, and correcting any documented micronutrient deficiencies including vitamin D. That's not a secret. That's just what works.